Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 5/20 | 0.37 |
| ▸ | THRA | P10827 | 4/20 | 0.37 |
| ▸ | PPARG | P37231 | 4/20 | 0.37 |
| ▸ | RXRA | P19793 | 3/20 | 0.37 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.37 |
| ▸ | ITGAV | P06756 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.33 |
| ▸ | TTR | P02766 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | HTR1A | P08908 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | HTR2B | P41595 | 2/20 | 0.33 |
| ▸ | PGR | P06401 | 2/20 | 0.33 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19665912 | 0.79 | THRB (0.66) | THRBTHRAPPARGRXRAITGB3 | |
| SCHEMBL19677574 | 0.76 | THRB (0.51) | THRBTHRAPPARGRXRAITGB3 | |
| SCHEMBL9438011 | 0.70 | ITGB3 (0.35) | THRBTHRAPPARGRXRAITGB3 | |
| SCHEMBL3846272 | 0.69 | GSTP1 (0.46) | HSD17B10ALDH1A1PTGS2POLBGSTP1 | |
| SCHEMBL19679558 | 0.66 | THRB (0.62) | THRBTHRAPPARGRXRAITGB3 | |
| SCHEMBL16395567 | 0.65 | HTT (0.38) | MEN1KMT2ALMNAHSD17B10POLB | |
| SCHEMBL16395030 | 0.64 | GSTP1 (0.41) | KMT2ALMNAHSD17B10HTR2BALDH1A1 | |
| SCHEMBL16395285 | 0.62 | GSTP1 (0.40) | HSD17B10ALDH1A1POLBGSTP1 | |
| SCHEMBL16395119 | 0.62 | MAOB (0.42) | HSD17B10ALDH1A1MAPTPOLBGSTP1 | |
| SCHEMBL8425554 | 0.60 | CA1 (0.44) | THRBMEN1KMT2AALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10695436-B2 | Non-cleavable polymer conjugated with alpha V beta 3 integrin thyroid antagonists | NANOPHARMACEUTICALS, LLC (US) | 2020-06-30 | — | — | US | disclosed |
| US-20190111145-A1 | NON-CLEAVABLE POLYMER CONJUGATED WITH ALPHA V BETA 3 INTEGRIN THYROID ANTAGONISTS | NANOPHARMACEUTICALS, LLC | 2019-04-18 | — | — | US | disclosed |
| EP-3463477-A1 | NON-CLEAVABLE POLYMER CONJUGATED WITH avß3 INTEGRIN THYROID ANTAGONISTS | NanoPharmaceuticals LLC (US) | 2019-04-10 | — | — | EP | disclosed |
| US-10201616-B2 | Non-cleavable polymer conjugated with αVβ3 integrin thyroid antagonists | NANOPHARMACEUTICALS, LLC (US) | 2019-02-12 | — | — | US | disclosed |
| WO-2017214299-A1 | NON-CLEAVABLE POLYMER CONJUGATED WITH αvβ3 INTEGRIN THYROID ANTAGONISTS | NANOPHARMACEUTICALS, LLC (US) | 2017-12-14 | — | — | WO | disclosed |
| US-20170348425-A1 | NON-CLEAVABLE POLYMER CONJUGATED WITH ALPHA V BETA 3 INTEGRIN THYROID ANTAGONISTS | NANOPHARMACEUTICALS, LLC | 2017-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10201616-B2 | Non-cleavable polymer conjugated with αVβ3 integrin thyroid antagonists | CD44, THRA, TSHR | THRB 6/4885THRA 2/4885PPARG 955/4885 |
| US-20170348425-A1 | NON-CLEAVABLE POLYMER CONJUGATED WITH ALPHA V BETA 3 INTEGRIN THYROID ANTAGONISTS | THRA, CD44, ITGAV | THRB 5/4885THRA 1/4885PPARG 861/4885 |
| US-20190111145-A1 | NON-CLEAVABLE POLYMER CONJUGATED WITH ALPHA V BETA 3 INTEGRIN THYROID ANTAGONISTS | THRA, CD44, ITGAV | THRB 5/4885THRA 1/4885PPARG 861/4885 |
| US-10695436-B2 | Non-cleavable polymer conjugated with alpha V beta 3 integrin thyroid antagonists | THRA, CD44, ITGAV | THRB 5/4885THRA 1/4885PPARG 861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.